Clinical Trials Directory

Trials / Completed

CompletedNCT07352631

A Novel 532-nm Picosecond Laser for Freckle Treatment in Chinese Patients

Efficacy and Safety of a Novel 532-nm Picosecond Nd:YAG Laser for the Treatment of Freckles in Chinese Patients: A Prospective, Randomized, Split-Face Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Beijing Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial was to learn if a novel laser device works as well and is as safe as an already approved laser device for removing freckles on the face. The main questions it aimed to answer were: After 8 weeks, did the novel laser make freckles fade by 60% or more for a similar number of participants as the approved laser? What side effects did participants have from either laser? Researchers compared the results from two sides of each participant's face to see if the novel laser worked as well as the approved laser. One side of the face was treated with the novel laser, and the other side was treated with the approved laser. A computer randomly chose which side received which laser. Participants in this study: Were adults (aged 18-65) with similar freckles on both sides of their face. Received one laser treatment session, using the two different lasers on opposite sides of their face. Returned to the clinic for check-up visits about 4 weeks and 8 weeks after the treatment. Had photos taken of their face at each visit so doctors could compare the fading of their freckles. Answered questions about any pain during the treatment and their satisfaction with the results.

Conditions

Interventions

TypeNameDescription
DEVICENd:YAG Picosecond Laser Therapy DeviceThis is an investigational medical device. It is a Nd:YAG laser system that generates picosecond-duration pulses of light at a wavelength of 532 nanometers (nm). It is designed for the treatment of benign epidermal pigmented lesions, including freckles, through selective photothermolysis and photomechanical effects.
DEVICENd:YAG Picosecond Laser Therapy SystemThis is a marketed (approved) medical device used as an active comparator. It is a Nd:YAG laser system that generates picosecond-duration pulses of light at a wavelength of 532 nanometers (nm). It is indicated for the treatment of benign epidermal pigmented lesions, including freckles.

Timeline

Start date
2024-12-11
Primary completion
2025-06-12
Completion
2025-08-27
First posted
2026-01-20
Last updated
2026-01-21

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07352631. Inclusion in this directory is not an endorsement.

A Novel 532-nm Picosecond Laser for Freckle Treatment in Chinese Patients (NCT07352631) · Clinical Trials Directory